David Geller, MD, PhD
Associate Professor of Medicine (Nephrology)DownloadHi-Res Photo
Cards
Appointments
Nephrology
Primary
Contact Info
About
Copy Link
Titles
Associate Professor of Medicine (Nephrology)
Appointments
Nephrology
Associate Professor on TermPrimary
Other Departments & Organizations
Education & Training
- Fellow
- Yale University School of Medicine (1999)
- Resident
- Yale-New Haven Hospital (1996)
- PhD
- New York University (1993)
- MD
- New York University (1993)
- BA
- Dartmouth College (1986)
Research
Copy Link
Overview
Medical Research Interests
Cardiovascular Diseases; Hypertension; Nephrology; Receptors, Mineralocorticoid
Research at a Glance
Yale Co-Authors
Frequent collaborators of David Geller's published research.
Publications Timeline
A big-picture view of David Geller's research output by year.
Research Interests
Research topics David Geller is interested in exploring.
Susan T Crowley, MD, MBA, FASN
10Publications
2,611Citations
Receptors, Mineralocorticoid
Hypertension
Publications
2024
Incremental hemodialysis transition in veterans and nonveterans with kidney failure
Rhee C, Kovesdy C, Unruh M, Crowley S, Geller D, Goldfarb D, Kraut J, Rastegar M, Rifkin I, Kalantar-Zadeh K. Incremental hemodialysis transition in veterans and nonveterans with kidney failure. Current Opinion In Nephrology & Hypertension 2024, 34: 33-40. PMID: 39611277, DOI: 10.1097/mnh.0000000000001040.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsCitations
2023
Chapter 8 Familial hyperaldosteronism
Pappachan J, Fernandez C, Geller D. Chapter 8 Familial hyperaldosteronism. 2023, 105-112. DOI: 10.1016/b978-0-323-96120-2.00016-9.ChaptersCitations
2012
Erratum: Corrigendum: Epigenetic modulation of the renal β-adrenergic–WNK4 pathway in salt-sensitive hypertension
Mu S, Shimosawa T, Ogura S, Wang H, Uetake Y, Kawakami-Mori F, Marumo T, Yatomi Y, Geller D, Tanaka H, Fujita T. Erratum: Corrigendum: Epigenetic modulation of the renal β-adrenergic–WNK4 pathway in salt-sensitive hypertension. Nature Medicine 2012, 18: 630-630. DOI: 10.1038/nm0412-630b.Commentaries, Editorials and Letters
2011
Erratum: Corrigendum: Epigenetic modulation of the renal β-adrenergic–WNK4 pathway in salt-sensitive hypertension
Mu S, Shimosawa T, Ogura S, Wang H, Uetake Y, Kawakami-Mori F, Marumo T, Yatomi Y, Geller D, Tanaka H, Fujita T. Erratum: Corrigendum: Epigenetic modulation of the renal β-adrenergic–WNK4 pathway in salt-sensitive hypertension. Nature Medicine 2011, 17: 1220-1020. DOI: 10.1038/nm0811-1020.Commentaries, Editorials and LettersCitations
2009
Chapter 18 Pseudohypaldosteronism Type 1 and Hypertension Exacerbated in Pregnancy
Geller D. Chapter 18 Pseudohypaldosteronism Type 1 and Hypertension Exacerbated in Pregnancy. 2009, 301-312. DOI: 10.1016/b978-0-12-449851-8.00018-8.ChaptersCitations
2003
Activating and inactivating mutations of the human mineralocorticoid receptor
Geller D. Activating and inactivating mutations of the human mineralocorticoid receptor. Current Opinion In Endocrinology Diabetes And Obesity 2003, 10: 186-190. DOI: 10.1097/00060793-200306000-00005.Peer-Reviewed Original Research
2001
A mineralocorticoid receptor mutation causing human hypertension
Geller D. A mineralocorticoid receptor mutation causing human hypertension. Current Opinion In Nephrology & Hypertension 2001, 10: 661-665. PMID: 11496062, DOI: 10.1097/00041552-200109000-00018.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsCitationsMolecular Mechanisms of Human Hypertension
Lifton R, Gharavi A, Geller D. Molecular Mechanisms of Human Hypertension. Cell 2001, 104: 545-556. PMID: 11239411, DOI: 10.1016/s0092-8674(01)00241-0.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsCitationsAltmetric
2000
Activating Mineralocorticoid Receptor Mutation in Hypertension Exacerbated by Pregnancy
Geller D, Farhi A, Pinkerton N, Fradley M, Moritz M, Spitzer A, Meinke G, Tsai F, Sigler P, Lifton R. Activating Mineralocorticoid Receptor Mutation in Hypertension Exacerbated by Pregnancy. Science 2000, 289: 119-123. PMID: 10884226, DOI: 10.1126/science.289.5476.119.Peer-Reviewed Original ResearchCitationsAltmetricMeSH KeywordsAdolescentAldosteroneAmino Acid SequenceAmino Acid SubstitutionBase SequenceBinding, CompetitiveDimerizationFemaleHeterozygoteHumansHypertensionMaleModels, MolecularMolecular Sequence DataPedigreePoint MutationPregnancyPregnancy Complications, CardiovascularProgesteroneProtein ConformationProtein Structure, SecondaryReceptors, MineralocorticoidReceptors, SteroidSteroids
1998
Mutations in the mineralocorticoid receptor gene cause autosomal dominant pseudohypoaldosteronism type I
Geller D, Rodriguez-Soriano J, Boado A, Schifter S, Bayer M, Chang S, Lifton R. Mutations in the mineralocorticoid receptor gene cause autosomal dominant pseudohypoaldosteronism type I. Nature Genetics 1998, 19: 279-281. PMID: 9662404, DOI: 10.1038/966.Commentaries, Editorials and LettersCitationsAltmetric
Academic Achievements & Community Involvement
Copy Link
Activities
activity Intern Selection Committee
2004 - PresentCommitteesMemberactivity Homeostasis Course
2014 - PresentCommitteesCo-Directoractivity Veterans Affairs West Haven, Water Safety
2014 - PresentCommitteesMemberactivity Renal Module
2013 - 2015CommitteesDirectoractivity NIH, Clinical and Integrative Cardiovascular Science
2004 - 2005Professional OrganizationsAd-hoc Member
Honors
honor Young Investigator Award
07/01/2001International AwardInternational Aldosterone ConferenceDetailsGermanyhonor Travel Grant Award
07/01/2000National AwardEndocrine SocietyDetailsUnited Stateshonor Top Research Advance in Heart Disease and Stroke
07/01/1999National AwardAmerican Heart AssociationDetailsUnited States
Get In Touch
Copy Link
Contacts
Academic Office Number